Cargando…
Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections
Respiratory tract infections (RTIs) represent a serious problem because they are one of the most common cause of human death by infection. The search for the treatment of those diseases has therefore a great importance. In this study we provide an overview of the currently available treatments for R...
Autores principales: | Braido, F, Tarantini, F, Ghiglione, V, Melioli, G, Canonica, G W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695191/ https://www.ncbi.nlm.nih.gov/pubmed/18229572 |
Ejemplares similares
-
May We Strengthen the Human Natural Defenses with Bacterial
Lysates?
por: Villa, Elisa, et al.
Publicado: (2010) -
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial
por: Braido, Fulvio, et al.
Publicado: (2014) -
Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016) -
CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect
por: Chiappori, Alessandra, et al.
Publicado: (2016) -
Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation
por: Suárez, Norma, et al.
Publicado: (2020)